Ngā hua rapu - Mikhail Kalinichev

  • E whakaatu ana i te 1 - 7 hua o te 7
Whakamahine hua
  1. 1
    Early Neonatal Experience of Long-Evans Rats Results in Long-lasting Changes in Reactivity to a Novel Environment and Morphine-induced Sensitization and Tolerance

    Early Neonatal Experience of Long-Evans Rats Results in Long-lasting Changes in Reactivity to a Novel Environment and Morphine-induced Sensitization and Tolerance mā Mikhail Kalinichev

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania

    Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania mā Mikhail Kalinichev, Lee A. Dawson

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    The safety of botulinum neurotoxin type A's intraarticular application in experimental animals

    The safety of botulinum neurotoxin type A's intraarticular application in experimental animals mā Ana Dugonjić Okroša, Victor Ricardo Manuel Muñoz-Lora, Ivica Matak, Lidija Bach‐Rojecky, Mikhail Kalinichev, Zdravko Lacković

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Antinociceptive Actions of Botulinum Toxin A1 on Immunogenic Hypersensitivity in Temporomandibular Joint of Rats

    Antinociceptive Actions of Botulinum Toxin A1 on Immunogenic Hypersensitivity in Temporomandibular Joint of Rats mā Victor Ricardo Manuel Muñoz-Lora, Ana Dugonjić Okroša, Ivica Matak, Altair Antoninha Del Bel Cury, Mikhail Kalinichev, Zdravko Lacković

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The Expanding Therapeutic Utility of Botulinum Neurotoxins

    The Expanding Therapeutic Utility of Botulinum Neurotoxins mā Elena Fonfría, Jacquie Maignel, Stéphane Lezmi, Vincent Martin, Andrew Splevins, Saif Shubber, Mikhail Kalinichev, Keith Foster, Philippe Picaut, Johannes Krupp

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders

    Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders mā Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert M. Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli, Sylvain Célanire

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models

    Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models mā Mark Elliott, Christine Favre‐Guilmard, Sai Liu, Jacquie Maignel, Geoffrey Masuyer, Matthew Beard, Christopher Boone, Denis Carré, Mikhail Kalinichev, Stéphane Lezmi, Imran Mir, Camille Nicoleau, Shilpa Palan, Cindy Périer, Elsa Raban, Sicai Zhang, Min Dong, Pål Stenmark, Johannes Krupp

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: